Repligen Corp
(NAS:RGEN)
$
154.86
0.16 (0.1%)
Market Cap: 8.68 Bil
Enterprise Value: 8.56 Bil
PE Ratio: 0
PB Ratio: 4.30
GF Score: 94/100 
Repligen Corp at Stifel Healthcare Conference Transcript
Nov 16, 2022 / 07:25PM GMT
Release Date Price:
$190.97
(-9.42%)
Daniel Anthony Arias
Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Analyst
Here we go. Let's resume with the Life Sciences and Diagnostics portion of the Stifel Healthcare Conference. Happy to have Jon Snodgres, CFO of Repligen with us. Jon, thanks a bunch for being here.
Anthony J. Hunt
Repligen Corporation - President, CEO & Director
It's our pleasure.
Daniel Anthony Arias
Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Analyst
I think maybe the place to start would just be to have you make a couple of introductory comments that you wanted to relay, and then we can just jump into some Q&A after that.
Jon K. Snodgres
Repligen Corporation - CFO
Sounds good. And thanks for having us here. It's really a pleasure to actually get to see a lot of familiar faces today. It's been a while. So glad that you guys are doing the real deal here and having this face-to-face. It's fantastic.
So
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers